6
Oct
2026

Shenyang BrightGrandeur Pharma

Exhibitor at CPHI Milan 2026 stand 20H69, Finished Dosage & Formulation
About Us

Shenyang Everbright Pharmaceutical Co., Ltd. was founded on January 22, 1999. It is a high-tech pharmaceutical manufacturing enterprise located at No. 31 Songhuahu Street, Shenyang Economic and Technological Development Area.The company mainly engages in the production of small-volume injections, lyophilized powder injections (including hormonal drugs) and active pharmaceutical ingredients (APIs) such as potassium aspartate. Its flagship products include dexamethasone sodium phosphate for injection, urokinase for injection and chorionic gonadotropin for injection. Covering an area of ...

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Employees:
    50 - 99
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20H69, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Chorionic Gonadotrophin for Injection

    Product Chorionic Gonadotrophin for Injection

    Chorionic Gonadotrophin for Injection is a gonadotropin injectable preparation whose main active ingredient is human chorionic gonadotropin (HCG). By supplementing the level of gonadotropin in the body, it regulates reproductive endocrine function. It is indicated for anovulatory infertility, luteal phase ...
  • Omeprazole Sodium for Injection

    Product Omeprazole Sodium for Injection

    Injection Omeprazole Sodium is a potent gastric acid inhibitor belonging to the class of proton pump inhibitors (PPIs). It works by directly targeting the "final switch" of gastric acid secretion—the proton pump—to rapidly and effectively suppress acid production.

    This product is a prescription-...
  • Products  Catalog

    Product Products Catalog

    We specialize in the production of lyophilized powder injections, including hormone-based formulations. With an annual production capacity exceeding 20 million vials, we also offer reliable Contract Manufacturing Organization (CMO) services. Please refer to our product catalog for detailed specifications.
  • Urokinase for Injection

    Product Urokinase for Injection

    Urokinase for Injection is a thrombolytic agent that acts directly on the fibrinolytic system.
    Core Indications:Acute Cardiovascular Embolism: Acute myocardial infarction, acute massive pulmonary embolism.
    Acute Cerebrovascular Embolism: Acute phase of cerebral embolism.
    Perip...